Interleukin-10 inhibits the capacity of synovial macrophages to function as antigen-presenting cells

British Journal of Rheumatology

Volumn 37, Issue 11, 1998, Pages 1207-1214

  Mottonen M ^a,d   Isomaki P ^a   Saario, R ^b   Toivanen, P ^a   Punnonen, J ^a,c   Lassila, O ^a  

^a Turku University   (Finland)

^b UNIVERSITY OF TURKU   (Finland)

^c MAXYGEN INC   (United States)

^d TURKU UNIVERSITY   (Finland)

Author keywords

Antigen presenting cells; Co stimulatory molecules; Interleukin 10; Rheumatoid arthritis

Indexed keywords

CD14 ANTIGEN; CD40 ANTIGEN; CD86 ANTIGEN; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; HLA DR ANTIGEN; INTERLEUKIN 10; INTERLEUKIN 4; TUMOR NECROSIS FACTOR ALPHA;

ADULT; AGED; ANTIGEN EXPRESSION; ANTIGEN PRESENTING CELL; ARTICLE; CELL DIFFERENTIATION; CLINICAL ARTICLE; CONTROLLED STUDY; DENDRITIC CELL; FLOW CYTOMETRY; HUMAN; HUMAN CELL; MACROPHAGE; MIXED LYMPHOCYTE REACTION; PHENOTYPE; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; SYNOVIAL FLUID; T LYMPHOCYTE ACTIVATION;

ADULT; AGED; ANTIGEN PRESENTATION; ANTIGENS, CD40; ANTIGENS, CD80; ARTHRITIS, RHEUMATOID; DOWN-REGULATION; FEMALE; GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR; HUMANS; INTERLEUKIN-10; MACROPHAGES; MALE; MIDDLE AGED; SYNOVIAL FLUID; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0031759651     PISSN: 02637103     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (50)

1. Lassila O, Vainio O, Matzinger P. Can B cells turn on T cells? Nature 1988;334:253-5.
2. Feldmann M, Brennan FM, Maini RN. Rheumatoid arthritis. Cell 1996;85:307-10.
3. Firestein GS, Zvaifler NJ. Peripheral blood and synovial fluid monocyte activation in inflammatory arthritis. I. A cytofluorographic study of monocyte differentiation antigens and class II antigens and their regulation by y-interferon. Arthritis Rheum 1987;30:857-63.
4. Liu MF, Kohsaka H, Sakurai H et al. The presence of costimulatory molecules CD86 and CD28 in rheumatoid arthritis synovium. Arthritis Rheum 1996;39:110-4.
5. Thomas R, Quinn C. Role of CD86 in the synovium. J Immunol 1996;156:3074-86.
6. Thomas R, Davis LS, Lipsky PE. Rheumatoid synovium is enriched in mature antigen-presenting dendritic cells. J Immunol 1994;152:2613-23.
7. Freeman GJ, Freedman AS, Segil JM, Lee G, Whitman JF, Nadler LM. B7, a new member of the Ig superfamily with unique expression on activated and neoplastic B cells. J Immunol 1989;143:2714-22.
8. Azuma M, Ito D, Yagita H et al. B70 antigen is a second ligand for CTLA-4 and CD28. Nature 1993;366:76-9.
9. Freeman GJ, Gribben JG, Boussiotis VA et al. Cloning of B7-2: a CTLA-4 counter-receptor that costimulates human T cell proliferation. Science 1993;262:909-11.
10. Boussiotis VA, Freeman GJ, Gribben JG, Nadler LM. The role of B7-1/B7-2:CD28/CTLA-4 pathways in the prevention of anergy, induction of productive immunity and down-regulation of the immune response. Immunol Rev 1996;153:5-26.
11. Lenschow DJ, Walunas TL, Bluestone JA. CD28/B7 system of T cell costimulation. Annu Rev Immunol 1996;14:233-58.
12. Borriello F, Sethna MP, Boyd SD et al. B7-1 and B7-2 have overlapping, critical roles in immunoglobulin class switching and germinal center formation. Immunity 1997;6:303-13.
13. Knoerzer DB, Karr RW, Schwartz BD, Mengle-Gaw LJ. Collagen induced arthritis in the BB rat. Prevention of disease by treatment with CTLA-4-Ig. J Clin Invest 1995;96:987-93.
14. Stamenkovic I, Clark EA, Seed B. A B-lymphocyte activation molecule related to the nerve growth factor receptor and induced by cytokines in carcinomas. EMBO J 1989;8:1403-10.
15. van Kooten C, Banchereau J. CD40-CD40 ligand: a multifunctional receptor-ligand pair. Adv Immunol 1996;61:1-77.
16. + T-cell responses. Immunol Today 1996;17:410-4.
17. Noelle RJ. CD40 and its ligand in host defence. Immunity 1996;4:415-9.
18. Caux C, Massacrier C, Vanbervliet B et al. Activation of human dendritic cells through CD40 cross-linking. J Exp Med 1994;180:1263-72.
19. Cella M, Scheidegger D, Palmer-Lehmann K, Lane P, Lanzavecchia A, Alber G. Ligation of CD40 on dendritic cells triggers production of high levels of interleukin-12 and enhances T cell stimulatory capacity. J Exp Med 1996;184:747-52.
20. Kiener PA, Moran-Davis P, Rankin BM, Wahl AF, Aruffo A, Hollenbaugh D. Stimulation of CD40 with purified soluble gp39 induces proinflammatory responses in human monocytes. J Immunol 1995;155:4917-25.
21. Yang Y, Wilson JM. CD40 ligand-dependent T cell activation: requirement of B7-CD28 signalling through CD40. Science 1996;273:1862-4.
22. Alderson MR, Armitage RJ, Tough TW, Strockbine L, Fanslow WC, Spriggs MK. CD40 expression by human monocytes: regulation by cytokines and activation of monocytes by the ligand for CD40. J Exp Med 1993;178:669-74.
23. Durie FH, Fava RA, Foy TM, Aruffo A, Ledbetter JA, Noelle RJ. Prevention of collagen induced arthritis with an antibody gp39, the ligand for CD40. Science 1993;261:1328-30.
24. Feldmann M, Brennan FM, Maini RN. Role of cytokines in rheumatoid arthritis. Annu Rev Immunol 1996; 14:397-440.
25. de Waal Malefyt R, Yssel H, Roncarolo M-G, Spits H, de Vries J. Interleukin-10. Curr Opin Immunol 1992; 4:314-20.
26. + T cell clones and resting T cells. Specific inhibition of IL-2 production and proliferation. J Immunol 1993;150:4754-65.
27. Taga K, Tosato G. IL-10 inhibits human T cell proliferation and IL-2 production. J Immunol 1992;148:1143-8.
28. Katsikis PD, Chu C-Q, Brennan FM, Maini RN, Feldmann M. Immunoregulatory role of interleukin-10 in rheumatoid arthritis. J Exp Med 1994;179:1517-27.
29. Isomäki P, Luukkainen R, Saario R, Toivanen P, Punnonen J. Interleukin-10 functions as an anti-inflammatory cytokine in rheumatoid synovium. Arthritis Rheum 1996;39:386-95.
30. Arnett FC, Edworthy SM, Bloch DA et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988;31:315-24.
31. Sallusto F, Lanzavecchia A. Efficient presentation of soluble antigens by cultured human dendritic cells is maintained by granulocyte/macrophage colony-stimulating factor + interleukin-4 and downregulated by tumor necrosis factor α. J Exp Med 1994;179:1109-18.
32. Buelens C, Verhasselt V, De Groote D, Thielemans K, Goldman M, Willems F. Interleukin-10 prevents the generation of dendritic cells from human peripheral blood mononuclear cells cultured with interleukin-4 and granulocyte/macrophage colony-stimulating factor. Eur J Immunol 1997;27:756-62.
33. Summers KL, Daniel PB, O'Donnell JL, Hart DNJ. Dendritic cells in synovial fluid of chronic inflammatory arthritis lack CD80 surface expression. Clin Exp Immunol 1995;100:81-9.
34. Summers KL, O'Donnell JL, Williams LA, Hart DNJ. Expression and function of CD80 and CD86 costimulator molecules on synovial dendritic cells in chronic arthritis. Arthritis Rheum 1996;39:1287-91.
35. Balsa A, Dixey J, Sansom DM, Maddison PJ, Hall ND. Differential expression of the costimulatory molecules B7.1 (CD80) and B7.2 (CD86) in rheumatoid synovial tissue. Br J Rheumatol 1996;35:33-7.
36. Arend WP, Dayer J-M. Inhibition of the production and effects of interleukin-1 and tumor necrosis factor α in rheumatoid arthritis. Arthritis Rheum 1995;38:151-60.
37. Alvaro-Gracia JM, Zvaifler NJ, Firestein GS. Cytokines in chronic inflammatory arthritis. IV: Granulocyte/ macrophage colony-stimulating factor-mediated induction of class II MHC antigen on human monocytes: A possible role in rheumatoid arthritis. Eur J Immunol 1989;170:865-75.
38. Miossec P, Briolay J, Dechanet J, Wijdenes J, Martinez-Valdez H, Banchereau J. Inhibition of the production of proinflammatory cytokines and immunoglobulins by interleukin-4 in an ex vivo model of rheumatoid arthritis. Arthritis Rheum 1992;35:874-83.
39. Miossec P, Chomarat P, Dechanet J et al. Interleukin-4 inhibits bone resorption through an effect on osteoclasts and proinflammatory cytokines in an ex vivo model of bone resorption in rheumatoid arthritis. Arthritis Rheum 1994;37:1715-22.
40. Isomäki P, Luukkainen R, Toivanen P, Punnonen J. The presence of interleukin-13 in rheumatoid synovium and its anti-inflammatory effects on synovial fluid macrophages from patients with rheumatoid arthritis. Arthritis Rheum 1996;39:1693-702.
41. Creery WD, Diatz-Mitoma F, Filion L, Kumar A. Differential modulation of B7-1 and B7-2 isoform expression on human monocytes by cytokines which influence the development of T helper cell phenotype. Eur J Immunol 1996;26:1273-7.
42. Buelens C, Willems F, Delvaux A et al. Interleukin-10 differently regulates B7-1 (CD80) and B7-2 (CD86) expression on human peripheral blood dendritic cells. Eur J Immunol 1995;25:2668-72.
43. Mitra RS, Judge TA, Nestle FO, Turka LA, Nickoloff BJ. Psoriatic skin-derived dendritic cell function is inhibited by exogenous IL-10. Differential modulation of B7-1 (CD80) and B7-2 (CD86) expression. J Immunol 1995;154:2668-77.
44. Willems F, Marchant A, Delville JP et al. Interleukin-10 inhibits B7 and intercellular adhesion molecule-1 expression on human monocytes. Eur J Immunol 1994; 24:1007-9.
45. Chen E, Keystone EC, Fish EN. Restricted cytokine expression in rheumatoid arthritis. Arthritis Rheum 1993;36:901-10.
46. Firestein GS, Xu W-D, Townsend K et al. Cytokines in chronic inflammatory arthritis. I. Failure to detect T cell lymphokines (interleukin 2 and interleukin 3) and presence of macrophage colony-stimulating factor (CSF-1) and a novel mast cell growth factor in rheumatoid arthritis. J Exp Med 1988;168:1573-86.
47. Lotz M, Tsoukas CD, Robinson CA, Dinarello CA, Carson DA, Vaughan JH. Basis for defective responses of rheumatoid arthritis synovial fluid lymphocytes to anti-CD3 (T3) antibodies. J Clin Invest 1986;78: 713-21.
48. Schwartz RH. Models of T cell anergy. Is there a common molecular mechanism? J Exp Med 1996; 184:1-8.
49. + T cells. J Exp Med 1996;184:19-29.
50. + T-cell subset inhibits antigen-specific T-cell responses and prevents colitis. Nature 1997;389:737-42.